HPV establishes a highly effective immune evasion network by modulating Th1/Th2 differentiation, suppressing CTL activity, expanding Tregs, and recruiting TAMs, primarily through the actions of E5, E6, and E7 oncoproteins, thus enabling persistent infection and the progression of cervical cancer. The gene discussed is ARHGEF15; the disease is cervical carcinoma.